Artiva Biotherapeutics, Inc.
ARTV
56 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Jul 24 1:22 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 84,124 | $9.93 | $835.4K | 17,182,603(I) | View → |
| Jul 21, 2026 | Jul 24 1:22 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 120,582 | $9.55 | $1.2M | 17,098,479(I) | View → |
| Jul 13, 2026 | Jul 24 1:21 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 6,522 | $8.94 | $58.3K | 16,817,543(I) | View → |
| Jul 17, 2026 | Jul 20 10:08 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 7,882 | $8.95 | $70.5K | 16,977,927(I) | View → |
| Jul 16, 2026 | Jul 20 10:08 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 152,472 | $8.93 | $1.4M | 16,970,045(I) | View → |
| Jul 13, 2026 | Jul 14 11:00 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 6,552 | $8.94 | $58.6K | 16,817,573(I) | View → |
| Jul 10, 2026 | Jul 14 11:00 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 15,102 | $8.97 | $135.5K | 16,811,021(I) | View → |
| Jun 26, 2026 | Jun 29 8:20 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 1,876 | $8.98 | $16.8K | 16,795,919(I) | View → |
| Jun 25, 2026 | Jun 29 8:20 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 31,000 | $8.88 | $275.3K | 16,794,043(I) | View → |
| Jun 16, 2026 | Jun 16 10:08 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 124,893 | $8.89 | $1.1M | 16,763,043(I) | View → |
| Jun 15, 2026 | Jun 16 10:08 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 15,414 | $8.99 | $138.6K | 16,638,150(I) | View → |
| Jun 12, 2026 | Jun 16 10:08 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 391,019 | $8.57 | $3.4M | 16,622,736(I) | View → |
| Jun 11, 2026 | Jun 11 11:36 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 548,580 | $7.91 | $4.3M | 16,231,717(I) | View → |
| Jun 10, 2026 | Jun 11 11:36 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 103 | $7.00 | $721 | 15,683,137(I) | View → |
| Jun 9, 2026 | Jun 11 11:36 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 479,039 | $6.91 | $3.3M | 15,683,034(I) | View → |
| May 11, 2026 | May 28 8:34 PM | GC Corp.10% Owner | Purchase | 1,432,291 | $11.52 | $16.5M | 1,607,734(I) | View → |
| May 19, 2026 | May 20 1:52 AM | Heather RaymonSVP, Research and Development | Sale | 3,095 | $9.01 | $27.9K | 148,228(D) | View → |
| May 19, 2026 | May 20 1:52 AM | Christopher HoranChief Tech Operations Officer | Sale | 7,002 | $9.01 | $63.1K | 293,450(D) | View → |
| May 19, 2026 | May 20 1:51 AM | Jennifer BushCOO, CLO, Compliance Officer | Sale | 8,790 | $9.01 | $79.2K | 337,920(D) | View → |
| May 19, 2026 | May 20 1:50 AM | Subhashis BanerjeeChief Medical Officer | Sale | 7,037 | $9.01 | $63.4K | 144,963(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Aug 31 11:06 PM | Subhashis BanerjeeChief Medical Officer | Option Exercise | 5,306 | $1.92 | 74,265(D) | View → |
| Aug 18, 2026 | Aug 20 1:00 AM | Subhashis BanerjeeChief Medical Officer | Option Exercise | 429 | $1.92 | 79,571(D) | View → |
| May 18, 2026 | May 19 12:11 PM | Gines Diego MirallesPresident & Head of R&D | Grant/Award | 232,500 | $9.22 | 232,500(D) | View → |
| May 11, 2026 | May 13 9:45 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,170,138 | $0.0001 | 2,170,138(I) | View → |
| Feb 18, 2026 | Feb 20 2:50 AM | Elaine K. SorgDirector | Grant/Award | 27,500 | $4.15 | 27,500(D) | View → |
← Previous
Page 2 of 2